Cargando…
Development of a Precision Medicine Workflow in Hematological Cancers, Aalborg University Hospital, Denmark
Within recent years, many precision cancer medicine initiatives have been developed. Most of these have focused on solid cancers, while the potential of precision medicine for patients with hematological malignancies, especially in the relapse situation, are less elucidated. Here, we present a demog...
Autores principales: | Bødker, Julie S., Sønderkær, Mads, Vesteghem, Charles, Schmitz, Alexander, Brøndum, Rasmus F., Sommer, Mia, Rytter, Anne S., Nielsen, Marlene M., Madsen, Jakob, Jensen, Paw, Pedersen, Inge S., Grubach, Lykke, Severinsen, Marianne T., Roug, Anne S., El-Galaly, Tarec C., Dybkær, Karen, Bøgsted, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073219/ https://www.ncbi.nlm.nih.gov/pubmed/32013121 http://dx.doi.org/10.3390/cancers12020312 |
Ejemplares similares
-
Implementing the FAIR Data Principles in precision oncology: review of supporting initiatives
por: Vesteghem, Charles, et al.
Publicado: (2019) -
Normal myeloid progenitor cell subset-associated gene signatures for acute myeloid leukaemia subtyping with prognostic impact
por: Schönherz, Anna A., et al.
Publicado: (2020) -
The mutational profile of immune surveillance genes in diagnostic and refractory/relapsed DLBCLs
por: Nesic, Marijana, et al.
Publicado: (2021) -
Patient-reported outcomes in patients with hematological relapse or progressive disease: a longitudinal observational study
por: Sommer, Mia, et al.
Publicado: (2021) -
Shared care follow-up of patients with B-cell neoplasms based on nurse-led telephone consultations and PRO-data: a feasibility study from the North Denmark Region
por: Sommer, Mia, et al.
Publicado: (2020)